High Risk HPV Test_HD_Grouping
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332Copied!
Version20230616Copied!
PublisherB.well Connected Health StewardDate2023-06-16T01:00:56-04:00Descriptionb.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.
Purpose(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)
Expansion
Expansion error
Can't resolve code system: http://www.nlm.nih.gov/research/umls/hcpcs
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331
{
"description" : "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
"compose" : {
"exclude" : [ ],
"include" : [ {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331" ]
} ]
},
"date" : "2023-06-16T01:00:56-04:00",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-06-16T01:00:56.000-04:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "B.well Connected Health Steward",
"jurisdiction" : [ {
"extension" : [ {
"valueString" : "UNKNOWN",
"url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
} ]
} ],
"purpose" : "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)",
"name" : "HighRiskHPVTest_HD_Grouping",
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://loinc.org",
"code" : "21440-3",
"display" : "Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "30167-1",
"display" : "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification",
"version" : "2.74"
}, {
"system" : "http://snomed.info/sct",
"code" : "35904009",
"display" : "Human papillomavirus deoxyribonucleic acid detection (procedure)",
"version" : "http://snomed.info/sct/731000124108/version/20230301"
}, {
"system" : "http://loinc.org",
"code" : "38372-9",
"display" : "Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification",
"version" : "2.74"
}, {
"system" : "http://snomed.info/sct",
"code" : "441667007",
"display" : "Abnormal cervical Papanicolaou smear with positive human papillomavirus deoxyribonucleic acid test (finding)",
"version" : "http://snomed.info/sct/731000124108/version/20230301"
}, {
"system" : "http://snomed.info/sct",
"code" : "448651000124104",
"display" : "Microscopic examination of cervical Papanicolaou smear and Human papillomavirus deoxyribonucleic acid detection cotesting (procedure)",
"version" : "http://snomed.info/sct/731000124108/version/20230301"
}, {
"system" : "http://loinc.org",
"code" : "59263-4",
"display" : "Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "59264-2",
"display" : "Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "59420-0",
"display" : "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "69002-4",
"display" : "Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "71431-1",
"display" : "Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://snomed.info/sct",
"code" : "718591004",
"display" : "Cytology examination positive for high risk human papillomavirus (finding)",
"version" : "http://snomed.info/sct/731000124108/version/20230301"
}, {
"system" : "http://snomed.info/sct",
"code" : "720005005",
"display" : "Human papillomavirus deoxyribonucleic acid test positive, high risk on cervical specimen (finding)",
"version" : "http://snomed.info/sct/731000124108/version/20230301"
}, {
"system" : "http://loinc.org",
"code" : "75694-0",
"display" : "Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "77379-6",
"display" : "Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "77399-4",
"display" : "Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "77400-0",
"display" : "Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "82354-2",
"display" : "Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "82456-5",
"display" : "Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://loinc.org",
"code" : "82675-0",
"display" : "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "87624",
"display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)",
"version" : "2023"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "87625",
"display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed",
"version" : "2023"
}, {
"system" : "http://loinc.org",
"code" : "95539-3",
"display" : "Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection",
"version" : "2.74"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "G0476",
"display" : "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test",
"version" : "2023"
} ],
"offset" : 0,
"total" : 24,
"identifier" : "urn:uuid:baf9686f-a776-4be2-b748-05d2132ace46",
"timestamp" : "2023-06-29T17:45:18-04:00",
"parameter" : [ {
"name" : "count",
"valueInteger" : 1000
}, {
"name" : "offset",
"valueInteger" : 0
} ]
},
"title" : "High Risk HPV Test_HD_Grouping",
"extension" : [ {
"valueString" : "B.well Connected Health Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2023-06-16",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2023-06-16",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "4fd7f81b-810e-4f1b-8ce9-2c28a314dc81",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1235.332"
} ],
"version" : "20230616"
}